Home LiteratureArticle Details
PMID: 22932801 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.

Blood ·Vol. 120 ·No. 22 ·2012-11-22 ·Pages 4407-17

Gawad C, Pepin F, Carlton VE, Klinger M, Logan AC, Miklos DB, Faham M, Dahl G, Lacayo N

Abstract

The ability to distinguish clonal B-cell populations based on the sequence of their rearranged immunoglobulin heavy chain (IgH) locus is an important tool for diagnosing B-cell neoplasms and monitoring treatment response. Leukemic precursor B cells may continue to undergo recombination of the IgH gene after malignant transformation; however, the magnitude of evolution at the IgH locus is currently unknown. We used next-generation sequencing to characterize the repertoire of IgH sequences in diagnostic samples of 51 children with B precursor acute lymphoblastic leukemia (B-ALL). We identified clonal IgH rearrangements in 43 of 51 (84%) cases and found that the number of evolved IgH sequences per patient ranged dramatically from 0 to 4024. We demonstrate that the evolved IgH sequences are not the result of amplification artifacts and are unique to leukemic precursor B cells. In addition, the evolution often follows an allelic exclusion pattern, where only 1 of 2 rearranged IgH loci exhibit ongoing recombination. Thus, precursor B-cell leukemias maintain evolution at the IgH locus at levels that were previously underappreciated. This finding sheds light on the mechanisms associated with leukemic clonal evolution and may fundamentally change approaches for monitoring minimal residual disease burden.

MeSH Terms
Age Factors Algorithms Bone Marrow/pathology Case-Control Studies Child Child, Preschool Clonal Evolution/genetics,physiology DNA Mutational Analysis Genes, Immunoglobulin Heavy Chain/genetics Genetic Loci/genetics Humans Infant Infant, Newborn Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics,pathology Recurrence Validation Studies as Topic
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Gawad Charles
Division of Hematology-Oncology-Stem Cell Transplantation and Cancer Biology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. [email protected]
Pepin Francois
Carlton Victoria E H
Klinger Mark
Logan Aaron C
Miklos David B
Faham Malek
Dahl Gary
Lacayo Norman
References (42)
42 references, click to expand
  1. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements.
    J Immunol. 2010 Jun 15;184(12):6986-92 PMID: 20495067
  2. Ordered rearrangement of immunoglobulin heavy chain variable region segments.
    EMBO J. 1984 Jun;3(6):1209-19 PMID: 6086308
  3. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
    Leukemia. 1995 Nov;9(11):1847-50 PMID: 7475273
  4. Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease.
    Blood. 2002 Apr 1;99(7):2315-23 PMID: 11895762
  5. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.
    Blood. 2012 Aug 30;120(9):1868-76 PMID: 22442346
  6. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
    Cytometry B Clin Cytom. 2007;72 Suppl 1:S14-22 PMID: 17803189
  7. IMGT/junctionanalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (IG) and T cell receptors (TR).
    Cold Spring Harb Protoc. 2011 Jun 01;2011(6):716-25 PMID: 21632777
  8. Mechanism of relapse in pediatric acute lymphoblastic leukemia.
    Cell Cycle. 2008 May 15;7(10):1315-20 PMID: 18418081
  9. Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia.
    Blood. 1993 Feb 1;81(3):775-82 PMID: 8427969
  10. Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse.
    Blood. 1998 Aug 1;92(3):952-8 PMID: 9680364
  11. Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection.
    Leuk Res. 2001 Dec;25(12):1033-45 PMID: 11684274
  12. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia.
    Leukemia. 1997 Aug;11(8):1258-65 PMID: 9264379
  13. IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
    Oncotarget. 2011 Mar;2(3):178-85 PMID: 21399237
  14. IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia.
    Br J Haematol. 2006 Apr;133(1):50-8 PMID: 16512828
  15. Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
    J Exp Med. 2002 Sep 2;196(5):629-39 PMID: 12208878
  16. Acute lymphoblastic leukemia.
    N Engl J Med. 2004 Apr 8;350(15):1535-48 PMID: 15071128
  17. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.
    PLoS One. 2012;7(2):e30733 PMID: 22319583
  18. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment.
    Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21194-9 PMID: 22160699
  19. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.
    Leukemia. 2001 Jan;15(1):134-40 PMID: 11243381
  20. Somatic generation of antibody diversity.
    Nature. 1983 Apr 14;302(5909):575-81 PMID: 6300689
  21. Detection of minimal residual disease in acute leukemia by flow cytometry.
    Cytometry. 1999 Aug 15;38(4):139-52 PMID: 10440852
  22. Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia.
    J Mol Diagn. 2009 May;11(3):194-200 PMID: 19324994
  23. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
    J Clin Oncol. 2010 May 10;28(14):2339-47 PMID: 20385996
  24. Antibody repertoires generated by VH replacement and direct VH to JH joining.
    Immunity. 2006 Jul;25(1):43-53 PMID: 16860756
  25. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions.
    Proc Natl Acad Sci U S A. 1982 Jul;79(13):4118-22 PMID: 6287467
  26. Antigen receptor allelic exclusion: an update and reappraisal.
    J Immunol. 2010 Oct 1;185(7):3801-8 PMID: 20858891
  27. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.
    Am J Clin Pathol. 2009 Dec;132(6):940-9 PMID: 19926587
  28. VDJ recombination.
    Immunol Today. 1992 Aug;13(8):306-14 PMID: 1510813
  29. Biology, risk stratification, and therapy of pediatric acute leukemias: an update.
    J Clin Oncol. 2011 Feb 10;29(5):551-65 PMID: 21220611
  30. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Blood. 1994 Apr 15;83(8):2238-47 PMID: 8161789
  31. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia.
    Blood. 1993 Jul 15;82(2):581-9 PMID: 8329713
  32. Childhood acute lymphoblastic leukaemia--current status and future perspectives.
    Lancet Oncol. 2001 Oct;2(10):597-607 PMID: 11902549
  33. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process.
    Blood. 2004 May 1;103(9):3490-5 PMID: 14695232
  34. Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.
    Blood. 2003 Dec 15;102(13):4520-6 PMID: 12946997
  35. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia.
    Eur J Haematol. 1999 Sep;63(3):171-9 PMID: 10485272
  36. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.
    Blood. 2007 Jul 15;110(2):632-9 PMID: 17371950
  37. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing.
    Sci Transl Med. 2009 Dec 23;1(12):12ra23 PMID: 20161664
  38. The molecular basis and biological significance of VH replacement.
    Immunol Rev. 2004 Feb;197:231-42 PMID: 14962199
  39. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Blood. 2003 May 1;101(9):3635-40 PMID: 12506024
  40. Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH-VH gene replacements and VH-DJH gene rearrangements.
    Blood. 1996 Mar 15;87(6):2506-12 PMID: 8630417
  41. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage.
    Cell. 1997 Jan 10;88(1):65-72 PMID: 9019407
  42. V(D)J recombination: a functional definition of the joining signals.
    Genes Dev. 1989 Jul;3(7):1053-61 PMID: 2777075
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2012-11-22
Epub
2012-00-28
Pages
4407-17
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC3507147
Subset
IM
Grants
NCI NIH HHS · P01 CA049605 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]